Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This drug is a fixed-dose combination of three active ingredients commonly used in over-the-counter cold and flu remedies: - **Paracetamol (acetaminophen)** is an analgesic and antipyretic that reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system. - **Dimethindene maleate** is a first-generation selective H1 antihistamine that acts as an antagonist at histamine H1 receptors, reducing symptoms such as sneezing, itching, watery eyes, and runny nose. - **Phenylephrine hydrochloride** is a sympathomimetic decongestant that stimulates alpha-1 adrenergic receptors to constrict blood vessels in the nasal mucosa, thereby reducing swelling and congestion[3][4][5]. The primary indication for this combination is symptomatic relief of common cold or influenza-like illnesses—specifically targeting headache, fever, nasal congestion, sneezing, rhinorrhea (runny nose), sore throat, muscle aches, and related symptoms[1][2]. This product has been evaluated in clinical trials for efficacy and safety as an over-the-counter remedy for these conditions[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Paracetamol + Dimethindene maleate + Phenylephrine hydrochloride.